Phase II evaluation of pegylated interferon alfa-2b and temozolomide for the treatment of recurrent and progressive malignant gliomas
Phase of Trial: Phase II
Latest Information Update: 31 Jul 2006
At a glance
- Drugs Peginterferon alfa-2b; Temozolomide
- Indications Glioma
- Focus Therapeutic Use
- 31 Jul 2006 New trial record.